TRUFF
Red Light Holland Corp

1,912
Mkt Cap
$11.07M
Volume
587,299.00
52W High
$0.048
52W Low
$0.005
PE Ratio
-3.13
TRUFF Fundamentals
Price
$0.026
Prev Close
$0.028
Open
$0.0285
50D MA
$0.0172
Beta
0.87
Avg. Volume
138,274.91
EPS (Annual)
-$0.0072
P/B
1.02
$0.1721
Loading...
Loading...
News
all
press releases
News Placeholder
Clinical Breakthrough: Repeat Psilocybin Dosing Drives Lasting Improvements for Cancer Patients
Most clinical trials in psychedelic medicine have traditionally focused on the impact of a single treatment session. However, new data published this month is shifting that narrative, suggesting that psilocybin therapy may be more effective when structured as a repeatable, protocol-driven treatment rather than a one-time intervention. As regulatory pathways for these therapies accelerate, the focus is moving toward optimizing dosing schedules to maximize long-term patient outcomes. Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) released details today of a Phase 1 clinical study ...
AllPennyStocks.com·6d ago
<
...
1
>

Latest TRUFF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.